Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
Barry PJ, Mall MA, Álvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D; VX18-445-104 Study Group. Barry PJ, et al. N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665. N Engl J Med. 2021. PMID: 34437784 Free PMC article. Clinical Trial.
Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy.
Beswick DM, Humphries SM, Balkissoon CD, Strand M, Vladar EK, Ramakrishnan VR, Taylor-Cousar JL. Beswick DM, et al. Among authors: balkissoon cd. J Cyst Fibros. 2022 Mar;21(2):e141-e147. doi: 10.1016/j.jcf.2021.09.014. Epub 2021 Sep 29. J Cyst Fibros. 2022. PMID: 34598881 Free article.
Olfactory dysfunction in people with cystic fibrosis with at least one copy of F508del.
Beswick DM, Humphries SM, Balkissoon CD, Strand M, E Miller J, Khatiwada A, Vladar EK, Lynch DA, Taylor-Cousar JL. Beswick DM, et al. Among authors: balkissoon cd. Int Forum Allergy Rhinol. 2022 Jul;12(7):963-966. doi: 10.1002/alr.22946. Epub 2022 Jan 14. Int Forum Allergy Rhinol. 2022. PMID: 34908251 Free PMC article. No abstract available.
Objective and patient-based measures of chronic rhinosinusitis in people with cystic fibrosis treated with highly effective modulator therapy.
Beswick DM, Humphries SM, Miller JE, Balkissoon CD, Khatiwada A, Vladar EK, Ramakrishnan VR, Lynch DA, Taylor-Cousar JL. Beswick DM, et al. Among authors: balkissoon cd. Int Forum Allergy Rhinol. 2022 Nov;12(11):1435-1438. doi: 10.1002/alr.23016. Epub 2022 May 20. Int Forum Allergy Rhinol. 2022. PMID: 35595546 Free PMC article. No abstract available.